Monday, September 6, 2010
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Where our team of guest writers discuss what they think about the current NGP US Issues.
Peter Duncan
Director of Business Development
Director of Business Development
Can digital pathology save drug development?
Peter Duncan of Definiens discusses the potential of digital pathology.07 Jul 2010
Focus Area: Drug Discovery
SciFinder reaching more researchers at top pharmaceutical companies
Chemical Abstracts Service (CAS), a division of the American Chemical Society, has announced that its SciFinder® research tool is now in use at 48 of the top 50 pharmaceutical companies
No Comments
Executive forum: Vital statistics
Informatics has the potential to drive growth in the worldwide pharmaceuticals drug market to a massive US$3 trillion by 2020, according to research
No Comments
Transdermal drug delivery: revival of fortunes?
With thinning pipelines and fewer blockbusters, pharmaceutical companies are increasingly looking to innovative drug delivery routes to extend patent life.
No Comments
RNA Amplification – Preservation of a Precious Archive
Dr. Andrew I. Brooks
Associate Professor of Environmental Medicine and Genetics
No Comments
Source: www.ngpharma.com© 2010 GDS Publishing Ltd. All rights reserved.